Digitally Delivered Exercise in Helping People to Move More
Salaso Moving More: The Impact of Digitally Delivered Precision Exercise in Helping People to Move More
1 other identifier
interventional
96
1 country
1
Brief Summary
The main objective of this study is to examine the influence of the digital exercise prescription platform in increasing habitual physical activity in people on a weight management programme.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started May 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 18, 2022
CompletedFirst Submitted
Initial submission to the registry
June 15, 2023
CompletedFirst Posted
Study publicly available on registry
June 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedJune 26, 2023
July 1, 2022
1.1 years
June 15, 2023
June 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Habitual physical activity
Global Physical Activity Questionnaire
Change between baseline and 3 months (post intervention)
Study Arms (2)
Exercise
EXPERIMENTALRemote 12-week exercise intervention
Control/Routine Care
NO INTERVENTIONNo exercise intervention, continue with routine care
Interventions
Eligibility Criteria
You may qualify if:
- Enrolled into the KindEating programme with BCUHB
- ≥ 18 years of age
- Able to provide written informed consent
You may not qualify if:
- Any uncontrolled medical condition that is exacerbated by exercise
- Unstable angina, unstable or acute heart failure, new or uncontrolled arrhythmias, resting or uncontrolled tachycardia, uncontrolled hypertension \>180/100 (in either), symptomatic hypotension, febrile illness, acute uncontrolled psychiatric illness, other rapidly progressing terminal illness, uncontrolled diabetes \>16.7mmol, patient's currently undergoing anti-biotic treatment for cellulitis, acute infections active foot ulceration
- Inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bangor Universitylead
- Betsi Cadwaladr University Health Boardcollaborator
- Salaso Health Solutions Ltdcollaborator
Study Sites (1)
Betsi Cadwaladr University Health Board
Bangor, North Wales, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sophie E Harrison, PhD
Bangor University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 15, 2023
First Posted
June 26, 2023
Study Start
May 18, 2022
Primary Completion
July 1, 2023
Study Completion
August 1, 2023
Last Updated
June 26, 2023
Record last verified: 2022-07